While the difference in DNM1 levels between cancer patients with and without PCD was no longer statistically significant in this model, considering the smaller sample size and statistical power of this analysis, the direction of this difference is consistent with the main findings (Table 2 – Model B). This evidence concerns the gene DNM1 and cancer.